ABBOTT LABORATORIES
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $44.3 | $42.0 | $40.1 | $43.7 | $43.1 |
| Operating income | $8.1 | $6.8 | $6.5 | $8.4 | $8.4 |
| Net income | $6.5 | $13.4 | $5.7 | $6.9 | $7.1 |
| Cash Flow Statement | |||||
| Free cash flow | $7.4 | $6.4 | $5.1 | $7.8 | $8.6 |
| Dividends | $4.1 | $3.8 | $3.6 | $3.3 | $3.2 |
| Share repurchases | $0.9 | $1.3 | $1.2 | $3.8 | $2.3 |
Shares outstanding 1.7B · Free float 95.7%
Annual filing data through FY ended December 31, 2025; float as of September 14, 2026.